Previous close | 15.10 |
Open | 15.10 |
Bid | 15.70 x N/A |
Ask | 16.00 x N/A |
Day's range | 15.10 - 15.10 |
52-week range | 12.10 - 20.20 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NOVA LIMA, Brazil, June 05, 2024--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that the resolution set out in its Notice of Annual General Meeting dated May 17, 2024 was duly passed at its Annual General Meeting held today: the approval and ratification of Afya’s financial statements and the auditor’s report for the fiscal year ended December 31, 2023.
NOVA LIMA, Brazil, May 20, 2024--Notice is hereby given that an Annual General Meeting of the Company (the "AGM") will be held at the offices of Afya Participações S.A. (Nasdaq: AFYA; B3: A2FY34) (the "Company"), Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing the following link https://web.lumiconnect.com/283874046 (password: afya2024), on the 5th day of June 2024 at 10:00 a.m. BRT, for the purpose of
NOVA LIMA, Brazil, May 09, 2024--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).